Digestive Health
    Procedures

    GLP-1 and Endoscopy Prep: What Every Patient Should Know

    If your doctor has recommended an upper endoscopy and you take a GLP-1 medication, specific safety steps are essential. This guide covers everything you need to prepare.

    Published: April 3, 20268 min read

    Important: Always follow your gastroenterologist's specific pre-procedure instructions. This article provides general guidance only.

    An upper endoscopy (EGD) allows your doctor to examine the lining of your esophagus, stomach, and upper small intestine. For GLP-1 patients, the procedure requires additional preparation because of how these medications affect gastric emptying.

    Why GLP-1 Status Matters for Endoscopy

    Upper endoscopy carries a unique concern for GLP-1 patients: the scope enters through the esophagus directly into the stomach. If slowed gastric emptying has left food in the stomach:

    • The gastroenterologist cannot properly visualize the stomach lining
    • Food particles can obscure lesions, ulcers, or other pathology
    • Aspiration risk increases during sedation when the scope stimulates the gag reflex
    • The procedure may need to be canceled and rescheduled

    Preparation Protocol

    Pre-Endoscopy Checklist for GLP-1 Patients

    • 7 days before: Hold your weekly GLP-1 injection (skip the dose falling within 7 days of procedure)
    • 48 hours before: Consider switching to easily digestible foods (soups, smoothies, soft foods)
    • 24 hours before: Switch to clear liquids only (broth, water, apple juice, Jello without fruit)
    • 8-12 hours before: Nothing by mouth (NPO) — no food, no liquids (unless directed otherwise)
    • Day of procedure: Inform all providers of your GLP-1 medication use and last dose date

    What to Tell Your Doctors

    Communication between your providers is essential. Make sure all involved parties know:

    • The exact GLP-1 medication you take and dose
    • When you last injected
    • Any GI symptoms you are currently experiencing (nausea, fullness, bloating)
    • Other medications that might affect gastric motility

    What If Food Is Found in Your Stomach

    Despite proper preparation, some GLP-1 patients still have retained gastric contents. If this happens:

    • The gastroenterologist may suction out liquid contents and proceed
    • If significant solid food is present, the procedure may be aborted for safety
    • You may be asked to extend your fasting period and return on a different day
    • Some providers use point-of-care ultrasound before sedation to check for retained contents

    Resuming GLP-1 Treatment

    After an uncomplicated endoscopy, you can typically resume your GLP-1 medication at your next scheduled dose once you are eating and drinking normally. If biopsies were taken or if any abnormalities were found, discuss timing with your provider.

    Frequently Asked Questions

    Should I stop GLP-1 medication before an upper endoscopy?

    Yes. The American Society of Anesthesiologists recommends holding weekly GLP-1 injectables for 7 days before any procedure requiring sedation. Upper endoscopy involves passing a scope through the esophagus into the stomach — retained food from slowed gastric emptying is a direct safety concern.

    What happens if there is food in my stomach during endoscopy?

    If significant food is found in the stomach, the gastroenterologist may choose to proceed with caution, convert to a different technique, or cancel and reschedule the procedure. Retained food impairs visualization of the stomach lining and increases aspiration risk during sedation.

    How long should I fast before endoscopy while on GLP-1 medications?

    Standard fasting is 8 hours for solids and 2 hours for clear liquids. GLP-1 patients may be asked to fast for 12-24 hours for solids and to consume only clear liquids the evening before. Follow your specific provider's instructions, as recommendations may vary.

    Is the aspiration risk higher for endoscopy versus colonoscopy on GLP-1?

    The aspiration risk is similar for any procedure requiring sedation. However, upper endoscopy may carry slightly higher concern because the scope passes through the esophagus, which could stimulate the gag reflex and increase the chance of stomach contents entering the airway.

    Coordinated Care at Trimi

    Our providers help coordinate your GLP-1 treatment around other medical needs. Semaglutide from $99/mo, tirzepatide from $125/mo.

    Get Started

    Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting any medication or treatment program.

    Sources & References

    1. Wilding JPH et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. NEJM 2021;384:989-1002.
    2. Jastreboff AM et al. Tirzepatide Once Weekly for the Treatment of Obesity. NEJM 2022;387:205-216.
    3. Lincoff AM et al. Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes. NEJM 2023;389:2221-2232.
    4. FDA Prescribing Information for Wegovy (semaglutide) and Zepbound (tirzepatide).

    What does the current clinical evidence support for GLP-1-based weight management?

    GLP-1 receptor agonists (semaglutide, tirzepatide) have Phase 3 RCT evidence for chronic weight management in adults with BMI ≥30 or BMI ≥27 with a weight-related comorbidity. Trimi offers compounded preparations of the same active ingredients at $99/month (semaglutide) and $125/month (tirzepatide) on the annual plan, prepared per individual prescription by 503A community sterile compounding pharmacies and reviewed by a US-licensed clinician through Beluga Health's 50-state physician network. Compounded preparations are not themselves FDA-approved as drugs; the active ingredients are FDA-approved in the corresponding brand finished products. Eligibility is determined by a licensed clinician.

    Phase 3 RCT evidence base: STEP 1 (NEJM 2021), SURMOUNT-1 (NEJM 2022), SELECT (NEJM 2023), FLOW (NEJM 2024)
    Trimi pricing: $99/month semaglutide / $125/month tirzepatide on annual plan
    Clinical review: Dr. Asad Niazi, MD MPH via Beluga Health 50-state network

    Key Takeaways

    • Compounded semaglutide and compounded tirzepatide are prepared per individual prescription by 503A community sterile compounding pharmacies (VialsRx — Texas State Board pharmacy license #35264 — and GreenwichRx). The active ingredients (semaglutide, tirzepatide) are FDA-approved in the corresponding brand finished products (Wegovy / Ozempic and Zepbound / Mounjaro respectively). Compounded preparations are not themselves FDA-approved as drugs.
    • Eligibility for GLP-1 treatment is determined by a licensed clinician: BMI ≥30, or BMI ≥27 with at least one weight-related comorbidity (type 2 diabetes, hypertension, dyslipidemia, obstructive sleep apnea, cardiovascular disease). Contraindications include personal/family history of medullary thyroid carcinoma, MEN 2 syndrome, pancreatitis, severe gastrointestinal disease, severe renal impairment, pregnancy, and breastfeeding.
    • Common GLP-1 receptor agonist adverse effects include nausea, vomiting, diarrhea, constipation, and gallbladder events. Most are mild-to-moderate and concentrated during dose escalation. Severe gastrointestinal symptoms causing dehydration can increase acute kidney injury risk and should be reported to the prescribing clinician.
    • Trimi's clinical review is coordinated by Dr. Asad Niazi, MD MPH through Beluga Health's 50-state physician network. Trimi pricing: $99/month for compounded semaglutide and $125/month for compounded tirzepatide on the annual plan; flat across all prescribed doses within whichever plan, with no enrollment / consultation / shipping fees.
    • This is general information based on the cited sources, not medical advice. Treatment decisions require evaluation by a licensed clinician familiar with your individual medical history.

    Medically Reviewed

    TMRT

    Trimi Medical Review Team

    Clinical review workflow for GLP-1 safety, dosing, and access content

    Team-based medical review process documented in Trimi's Medical Review Policy

    Last reviewed: January 23, 2026

    TCCT

    Written by Trimi Clinical Content Team

    Medical Writers & Healthcare Professionals

    Our clinical content team includes registered nurses, pharmacists, and medical writers who specialize in translating complex medical information into clear, actionable guidance for patients.

    Medically reviewed by Trimi Medical Review Team, Clinical review workflow for GLP-1 safety, dosing, and access content

    What real Trimi patients say

    Verbatim quotes from Trimi's Facebook and Reddit community reviews. First name and last initial preserved per editorial policy.

    I'm on my 4th week. No side effects. 5 lb loss which seems slow to me. Food noise is much better. We shall see!

    Outcome: 5 lbs lost in 4 weeks; no side effects; food noise reduced

    Lynn SchweitzerFacebook
    21 lbs down in 6 weeks! So happy I started with you guys!

    Outcome: 21 lbs lost in 6 weeks

    Robyn Lynn CurtisFacebook

    Editorial Standards

    Trimi publishes patient education using a medical-review workflow, source-based claim checks, and dated updates for fast-changing pricing, access, and safety topics.

    Review our Editorial Policy and Medical Review Policy for more details about sourcing, updates, and reviewer attribution.

    Scientific References

    1. Garvey WT, Mechanick JI, Brett EM, et al. (2024). American Association of Clinical Endocrinology / American College of Endocrinology Comprehensive Clinical Practice Guidelines for Medical Care of Patients with Obesity. Endocrine Practice.Read StudyDOI: 10.4158/EP161365.GL
    2. American Heart Association (2021). Obesity and Cardiovascular Disease: A Scientific Statement From the American Heart Association. Circulation.Read StudyDOI: 10.1161/CIR.0000000000000973
    3. Apovian CM, Aronne LJ, Bessesen DH, et al. (2015). Pharmacological Management of Obesity: An Endocrine Society Clinical Practice Guideline. Journal of Clinical Endocrinology & Metabolism.Read StudyDOI: 10.1210/jc.2014-3415

    Was this article helpful?

    Keep Reading

    Evidence-based guide to combining the Mediterranean diet with GLP-1 medications. Learn why research supports this pairing, get sample meal plans, and discover how to maximize weight loss while preserv

    Buy compounded semaglutide online in Texas for $99/month. Learn about Texas telehealth laws, compounding pharmacy access, and how to start affordable GLP-1 weight loss treatment.

    Complete guide to semaglutide 1.7mg dosing. Learn about expected weight loss results, side effects at this higher dose, and how to decide between staying at 1.7mg or advancing to 2.4mg.

    Complete guide to combining semaglutide and metformin. Learn about safety, synergistic benefits for diabetes and weight loss, GI side effect management, and dose adjustment considerations.

    Start your GLP-1 journey — from $99/mo

    Get Started